Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 2.

Our second daily wrap-up features highlights from the key late breaking trials, and some of the most interesting abstracts presented at the meeting.

Key Late-Breaking Clinical Trials Covered:

• ROCKET-AF Trial – Rivaroxaban was compared with warfarin in patients with nonvalvular atrial fibrillation

• SMART-AV Trial – Compared 3 alternative AV optimization techniques and assess whether optimization of AV delay SmartDelay Algorithm would improve heart failure

• CLOSURE-I Trial – Compared safety and efficacy of STARFlex septal closure device versus best medical therapy in patients with stroke or TIA due to presumed paradoxical embolism through a PFO

Highlighted in the video is expert commentary from leaders in cardiology including:

• Robert M. Califf, MD – Professor of Cardiology, Vice Chancellor for Clinical Research, Director of the Duke Translational Medicine Institute

• Peter R. Kowey, MD – Chief of the Division of Cardiovascular Diseases, Lankenau Hospital and the Main Line Health System

• Anthony J. Furlan, MD – Chairman of Neurology, University Hospitals – Case Medical Center

• James Januzzi, MD – Director, Coronary Care Unit, Massachusetts General Hospital, Associate Professor, Harvard Medical School

• Kim Williams, MD – Division Chief, Cardiology, Dorothy Susan Timmis Endowed Chair in Cardiology, Department of Internal Medicine, Wayne State University School of Medicine

• Michelle A. Albert, MD, MPH – Assistant Professor, Harvard Medical School

Check back tomorrow for AHA Scientific Sessions Meetings in Minutes – Day 3.